Progyny Inc

Затворен

СекторЗдравеопазване

25.57 0.59

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

25.31

Максимум

25.8

Ключови измерители

By Trading Economics

Приходи

28M

52M

Продажби

22M

351M

P/E

Средно за сектора

28.461

57.371

EPS

0.34

Марж на печалбата

14.917

Служители

835

EBITDA

5.9M

44M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+33.72% upside

Дивиденти

By Acuity

Следващи печалби

5.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-495M

1.9B

Предишно отваряне

24.98

Предишно затваряне

25.57

Настроения в новините

By Acuity

51%

49%

283 / 340 Класиране в Healthcare

Progyny Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.08.2026 г., 19:36 ч. UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20.08.2026 г., 19:31 ч. UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18.08.2026 г., 20:06 ч. UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17.08.2026 г., 20:01 ч. UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14.08.2026 г., 20:06 ч. UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13.08.2026 г., 21:31 ч. UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12.08.2026 г., 20:01 ч. UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11.08.2026 г., 20:02 ч. UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7.08.2026 г., 20:02 ч. UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6.08.2026 г., 23:02 ч. UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31.07.2026 г., 19:46 ч. UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30.07.2026 г., 21:02 ч. UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29.07.2026 г., 18:55 ч. UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28.07.2026 г., 17:41 ч. UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24.07.2026 г., 15:06 ч. UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22.07.2026 г., 20:01 ч. UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20.07.2026 г., 17:16 ч. UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Сравнение с други в отрасъла

Ценова промяна

Progyny Inc Прогноза

Ценова цел

By TipRanks

33.72% нагоре

12-месечна прогноза

Среден 34.3 USD  33.72%

Висок 40 USD

Нисък 30 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Progyny Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

10 ratings

8

Купи

2

Задържане

0

Продай

Настроение

By Acuity

283 / 340 Класиране в Здравеопазване

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat